CLINICAL_TRIALS
trial_result
· 2026-07-14
Clinical Trial Results: Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola [Phase 2]
Summary
Phase 2 trial assessing immunogenicity and safety of a heterologous Ebola vaccine regimen; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Universiteit Antwerpen | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-07-14